Aurora Cannabis (ACB) Cash from Financing Activities (2017 - 2025)

Aurora Cannabis (ACB) posted quarterly Cash from Financing Activities of $1.3 million for Q4 2025, up 259.16% year-on-year from $348312.4 in Q4 2024, and up 226.32% on a QoQ basis from -$990318.3 in Q1 2025.

Aurora Cannabis (ACB) Cash from Financing Activities (2017 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has reported Cash from Financing Activities for 9 consecutive years, with $1.3 million the latest figure, recorded in Q4 2025.

  • Quarterly Cash from Financing Activities rose 259.16% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (up 138.95% YoY) and the FY2026 annual result came in at $3.5 million, up 211.42% from the prior year.
  • Cash from Financing Activities grew to $1.3 million in Q4 2025 per ACB's latest filing, from -$990318.3 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ACB reached as high as $129.9 million in Q1 2021 and fell as low as -$48.1 million in Q2 2021.
  • A 5-year average of $12.5 million and a median of $232500.0 in 2024 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2021 — Cash from Financing Activities sank 1215.42% — and 2025, when it jumped 259.16%.
  • Year by year, Cash from Financing Activities stood at -$5.9 million in 2021, then slumped by 680.38% to -$46.0 million in 2022, then jumped by 124.23% to $11.1 million in 2023, then plunged by 107.06% to -$786000.0 in 2024, then soared by 259.16% to $1.3 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $1.3 million, -$990318.3, and -$786000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.25 Mn
Dec 31, 2025 1.25 Mn
Mar 31, 2025 -990,318.31
Mar 31, 2025 -990,318.31
Dec 31, 2024 -786,000.00
Dec 31, 2024 -786,000.00
Sep 30, 2024 2.90 Mn
Sep 30, 2024 2.90 Mn
Jun 30, 2024 -4.61 Mn
Jun 30, 2024 -4.61 Mn
Mar 31, 2024 -3.62 Mn
Mar 31, 2024 -3.62 Mn
Dec 31, 2023 11.13 Mn
Dec 31, 2023 11.13 Mn
Sep 30, 2023 2.79 Mn
Sep 30, 2023 2.79 Mn
Dec 31, 2022 -45.96 Mn
Dec 31, 2022 -45.96 Mn
Sep 30, 2022 40.18 Mn
Sep 30, 2022 40.18 Mn